Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Running

SEB Scalable and Eco-friendly Bioproduction

Coordinator
Core Biogenesis, France
Runs
1 January 2023 to 31 December 2024
Status
Running
EU funding
€1.2m
Total cost
€1.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190139157

What the project is doing

In the project's own words, from its summary on CORDIS.

Core Biogenesis uses plant-based expression systems for the very large-scale and high-quality bioproduction of pharmaceutical-grade recombinant proteins. The latter are used as growth factors (GF) in synthetic cell culture media for clinical and commercial scale biomanufacturing of cell therapy. The company has developed a novel advanced proprietary bioprocess integrating breakthrough innovations overcoming major technical issues of plant systems by offering a 25-fold yield increase and a 10-fold cost reduction.

Its biomanufacturing platform will enable Core Biogenesis to fully exploit the great potential of plants for large and scalable production capacity as plants are well known to be the most promising system for production upscaling. Core Biogenesiss ambition is to position itself as the European leader in plant-based biomanufacturing by 2025.

Topics

Who is involved

OrganisationCityCountryRole
Core BiogenesisIllkirch GraffenstadenFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI